APA (7th ed.) Citation

S, D., PV, E., SS, J., B, S., & JJ, W. (2023). Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis. Lancet (London, England), 402(10415), 1833. https://doi.org/10.1016/S0140-6736(23)01619-7

Chicago Style (17th ed.) Citation

S, Devjani, Engel PV, Javadi SS, Smith B, and Wu JJ. "Efficacy of Rocatinlimab for Moderate-to-severe Atopic Dermatitis." Lancet (London, England) 402, no. 10415 (2023): 1833. https://doi.org/10.1016/S0140-6736(23)01619-7.

MLA (9th ed.) Citation

S, Devjani, et al. "Efficacy of Rocatinlimab for Moderate-to-severe Atopic Dermatitis." Lancet (London, England), vol. 402, no. 10415, 2023, p. 1833, https://doi.org/10.1016/S0140-6736(23)01619-7.